This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Kissei Pharmaceutical Co., Ltd.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Kyosuke Nakamura: Innovator in Hypoxanthine Compounds
Introduction
Kyosuke Nakamura is a notable inventor based in Joetsu, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of hypoxanthine compounds. His work focuses on innovative solutions for treating inflammatory bowel diseases.
Latest Patents
Kyosuke Nakamura holds 1 patent related to hypoxanthine compounds. This patent describes a hypoxanthine compound or a pharmaceutically acceptable salt thereof. The compounds have a prolyl hydroxylase inhibitory effect, making them useful as agents for treating inflammatory bowel diseases such as ulcerative colitis. The invention also includes a method for treating these diseases by administering a pharmaceutical composition containing the hypoxanthine compound.
Career Highlights
Nakamura is associated with Kissei Pharmaceutical Co., Ltd., where he continues to advance his research and development efforts. His work has the potential to significantly impact the treatment options available for patients suffering from inflammatory bowel diseases.
Collaborations
Some of his coworkers include Yasushi Takigawa and Yusuke Kawabe, who contribute to the collaborative efforts in research and development at Kissei Pharmaceutical.
Conclusion
Kyosuke Nakamura's innovative work in hypoxanthine compounds showcases his commitment to improving healthcare solutions. His contributions are paving the way for new treatments in the pharmaceutical industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile